Romiplostim (Nplate) Dosage Calculator
Romiplostim (Nplate) is an FDA-approved Fc-peptide fusion protein (peptibody) that acts as a thrombopoietin receptor (c-Mpl) agonist.
1mcg · Weekly
Summary: Add 0.72mL BAC water to your 0.25mg vial. Draw to 0.3 units on a U-100 syringe for a 1mcg dose. This vial will last 250 doses.
Cycle Planner
Romiplostim (Nplate) Pharmacokinetics
Pharmacokinetics — Active Dose Over Time
t½ = ~3.5 days (median)Disclaimer: This curve is a simplified first-order exponential decay model. Actual pharmacokinetics vary based on injection site, individual metabolism, body composition, and other factors. Half-life values are approximate and based on available preclinical and clinical literature. Many research peptides lack formal human pharmacokinetic studies. This is for educational purposes only — not medical advice.
Romiplostim (Nplate) Dosing Protocol
| Level | Dose / Injection | Frequency |
|---|---|---|
| Beginner | 1mcg | Weekly |
| Moderate | 3mcg | Weekly |
| Aggressive | 10mcg | Weekly |
Note: FDA-approved thrombopoietin receptor agonist (peptibody). Weight-based dosing: 1-10 mcg/kg SC weekly. Adjust by 1 mcg/kg increments to achieve platelet count ≥50 × 10⁹/L. Requires regular CBC monitoring. REMS program applies.
About Romiplostim (Nplate)
Romiplostim (Nplate) is an FDA-approved Fc-peptide fusion protein (peptibody) that acts as a thrombopoietin receptor (c-Mpl) agonist. It stimulates megakaryopoiesis and platelet production by binding to and activating the TPO receptor, mimicking the action of endogenous thrombopoietin. Approved for the treatment of immune thrombocytopenia (ITP) in adults and pediatric patients who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Romiplostim increases platelet counts in a dose-dependent manner, typically within 1-2 weeks of initiation.